Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Somaxon Pharmaceuticals received early financing of $6.0M on 2009-07-15.
| Series | Round size | Date |
|---|---|---|
| Equity | $6.0M | 07/2009 |
| Investors | Security type |
|---|---|
| MPM Capital | Series C - Somaxon Pharmaceuticals |
| Domain Associates | Series C - Somaxon Pharmaceuticals |
| CDIB BioScience Ventures | Series C - Somaxon Pharmaceuticals |
| Montreux Equity Partners | Series C - Somaxon Pharmaceuticals |
| BA Venture Partners | Series C - Somaxon Pharmaceuticals |
| Domain Associates | Series B - Somaxon Pharmaceuticals |
| Montreux Equity Partners | Series B - Somaxon Pharmaceuticals |
| CDIB BioScience Ventures | Series B - Somaxon Pharmaceuticals |
| Fog City Capital | Series B - Somaxon Pharmaceuticals |
| Scale Venture Partners | Series B - Somaxon Pharmaceuticals |
Somaxon Pharmaceuticals's top competitor, AstraZeneca, earned an annual revenue of $25.9B.
Somaxon Pharmaceuticals's smallest competitor is Sebela Pharmaceuticals with revenue of $5.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Santarus | $70,584 | $218.0M | 290 | - |
| Xanodyne Pharmaceuticals | $68,613 | $18.8M | 100 | - |
| Pharmacia | $76,833 | $130.0M | 350 | - |
| AstraZeneca | $112,988 | $25.9B | 76,100 | 402 |
| Organon | $73,941 | $6.4B | 158 | 142 |
| Daiichi Sankyo | $82,543 | $9.0B | 15,348 | 47 |
| Sunovion Pharmaceuticals | $67,270 | $600.0M | 2,400 | 21 |
| Sebela Pharmaceuticals | $63,740 | $5.0M | 222 | 1 |
| PDI | $64,390 | $22.0M | 350 | 42 |
| Depomed | $72,486 | $342.7M | 494 | - |
Zippia gives an in-depth look into the details of Somaxon Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Somaxon Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Somaxon Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Somaxon Pharmaceuticals. The data presented on this page does not represent the view of Somaxon Pharmaceuticals and its employees or that of Zippia.
Somaxon Pharmaceuticals may also be known as or be related to SOMAXON PHARMACEUTICALS INC., Somaxon Pharmaceuticals, Somaxon Pharmaceuticals Inc and Somaxon Pharmaceuticals, Inc.